[1]Sacks D B, Arnold M, Bakris G L, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J]. Diabetes Care, 2023, 46(10): e151-e199.
[2]Anon. ACOG practice bulletin No. 190: gestational diabetes mellitus[J]. Obstet Gynecol, 2018, 131(2): e49-e64.
[3]中华医学会妇产科学分会产科学组, 中华医学会围产医学分会, 中国妇幼保健协会妊娠合并糖尿病专业委员会. 妊娠期高血糖诊治指南(2022)(第一部分)[J]. 中华妇产科杂志, 2022, 57(1): 3-12.
[4]中华医学会妇产科学分会产科学组, 中华医学会围产医学分会, 中国妇幼保健协会妊娠合并糖尿病专业委员会. 妊娠期高血糖诊治指南(2022)(第二部分)[J]. 中华妇产科杂志, 2022, 57(2): 81-90.
[5]Boggess K A, Valint A, Refuerzo J S, et al. Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy: the MOMPOD randomized clinical trial[J]. JAMA, 2023, 330(22): 2182-2190.
[6]Rademaker D, De Wit L, Duijnhoven R G, et al. Oral glucose-lowering agents vs insulin for gestational diabetes: a randomized clinical trial[J]. JAMA, 2025, 333(6): 470-478.
[7]Yu Y H, Platt R W, Reynier P, et al. Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: a population-based cohort study[J]. Diabetes Obes Metab, 2025, 27(2): 976-986.
[8]Mcevoy R P, Newman C, Egan A M, et al. A narrative review of metformin in pregnancy: navigating benefit and uncertainty[J]. Diabetes Obes Metab, 2025, 27(Suppl 3): 16-30.
[9]Given J E, Loane M, Garne E, et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study[J]. BMJ, 2018, 361: k2477.
[10]Bailey C J. Metformin: therapeutic profile in the treatment of type 2 diabetes[J]. Diabetes Obes Metab, 2024, 26 Suppl 3: 3-19.
[11]肖建中. 二甲双胍的作用机制新进展[J]. 中华糖尿病杂志, 2024, 16(7): 735-739.
[12]Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential[J]. Nat Rev Endocrinol, 2023, 19(8): 460-476.
[13]Andrzejewski S, Gravel S P, Pollak M, et al. Metformin directly acts on mitochondria to alter cellular bioenergetics[J]. Cancer Metab, 2014, 2: 12.
[14]Dutta S, Shah R B, Singhal S, et al. Metformin: a review of potential mechanism and therapeutic utility beyond diabetes[J]. Drug Des Devel Ther, 2023, 17: 1907-1932.
[15]LaMoia T E, Shulman G I. Cellular and molecular mechanisms of metformin action[J]. Endocr Rev, 2021, 42(1): 77-96.
[16]Turner R C. The U K Prospective Diabetes Study. A review[J]. Diabetes Care, 1998,21(Suppl 3):C35-C38.
[17]廖玖江, 漆洪波. 二甲双胍在妊娠期的应用及思考[J]. 中华围产医学杂志, 2024, 27(1): 13-18.
[18]Vanky E, Zahlsen K, Spigset O, et al. Placental passage of metformin in women with polycystic ovary syndrome[J]. Fertil Steril, 2005, 83(5): 1575-1578.
[19]Faure M C, Khoueiry R, Quanico J, et al. In utero exposure to metformin reduces the fertility of male offspring in adulthood[J]. Front Endocrinol, 2021, 12: 34745014.
[20]Bolte E, Dean T, Garcia B, et al. Initiation of metformin in early pregnancy results in fetal bioaccumulation, growth restriction, and renal dysmorphology in a primate model[J]. Am J Obstet Gynecol, 2024, 231(3): 352.e1-352.e16.
[21]Ijäs H, Vääräsmäki M, Saarela T, et al. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months[J]. BJOG, 2015, 122(7): 994-1000.
[22]Rowan J A, Rush E C, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age[J]. Diabetes Care, 2011, 34(10): 2279-2284.
[23]Rowan J A, Rush E C, Plank L D, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age[J]. BMJ Open Diabetes Res Care, 2018, 6(1): e000456.
[24]Tarry-Adkins J L, Aiken C E. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis[J]. PLoS Med, 2019, 16(8): e1002848.
[25]Rawat D, Gupta Y, Yadav A K, et al. Cardiometabolic outcomes in offspring of women treated with metformin versus insulin for gestational diabetes: a systematic review and meta-analysis[J]. Diabetes Metab Syndr, 2024, 18(9): 103134.
[26]Brand K M G, Saarelainen L, Sonajalg J, et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study[J]. BMJ Open Diabetes Res Care, 2022, 10(1): e002363.
[27]Dutta D, Sharma M, Nagendra L, et al. Long-term impact on offspring (5 to 11 years of age) of metformin use in pregnancy in mothers with diabetes: a systematic review and meta-analysis[J]. Endocr Pract, 2024, 30(9): 854-862.
[28]Panagiotopoulou O, Syngelaki A, Georgiopoulos G, et al. Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring[J]. Am J Obstet Gynecol, 2020, 223(2): 246.e1-246.e10.
[29]Tosti G, Barberio A, Tartaglione L, et al. Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond[J]. Front Endocrinol, 2023, 14: 1176623.
[30]李兰, 冉兴无. 二甲双胍宫内暴露对子代心血管系统影响的研究进展[J]. 中华医学杂志, 2025, 105(11): 855-860.
[31]Feig D S, Sanchez J J, Murphy K E, et al. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial[J]. Lancet Diabetes Endocrinol, 2023, 11(3): 191-202.
[32]Paschou SA, Shalit A, Gerontiti E, et al. Efficacy and safety of metformin during pregnancy: an update[J]. Endocrine, 2024,83(2):259-269.
[33]Mason T, Alesi S, Fernando M, et al. Metformin in gestational diabetes: physiological actions and clinical applications[J]. Nat Rev Endocrinol, 2025, 21(2): 77-91.
[34]Francisca S, Gloria A F, Marco P B, et al. Metformin exposure during pregnancy and lactation affects offsprings long-term body weight and adipose tissue mass Independent of the maternal metabolic state[J]. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6): 167258.
[35]Feig D S. Metformin for diabetes in pregnancy: are we closer to defining its role?[J]. JAMA, 2023, 330(22): 2167-2169.
[36]Hanem L G E, Salvesen Ø, Madsen A, et al. Maternal PCOS status and metformin in pregnancy: steroid hormones in 5-10 years old children from the PregMet randomized controlled study[J]. PLoS One, 2021, 16(9): e0257186.
[37]Carlsen S M, Vanky E. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns[J]. Hum Reprod, 2010, 25(3): 786-790.
[38]Forcato S, Montagnini B G, De Góes M L M, et al. Reproductive evaluations in female rat offspring exposed to metformin during intrauterine and intrauterine/lactational periods[J]. Reprod Toxicol, 2019, 87: 1-7.
[39]Forcato S, Novi D R B D S, Costa N O, et al. In utero and lactational exposure to metformin induces reproductive alterations in male rat offspring[J]. Reprod Toxicol, 2017, 74: 48-58.
[40]Tartarin P, Moison D, Guibert E, et al. Metformin exposure affects human and mouse fetal testicular cells[J]. Hum Reprod, 2012, 27(11): 3304-3314.
[41]Tseng C H. The effect of metformin on male reproductive function and prostate: an updated review[J]. World J Mens Health, 2022, 40(1): 11-29.
[42]Rozance P J, Brown L D, Wesolowski S R. Absence of metformin in fetal circulation following maternal administration in late gestation pregnant sheep[J]. Reprod Sci, 2024, 31(6): 1763-1766.
[43]Oner M, Cheng P T, Wang H Y, et al. Metformin alters dendrite development and synaptic plasticity in rat cortical neurons[J]. Biochem Biophys Res Commun, 2024, 710: 149874.
[44]Oner M, Chen M C, Cheng P T, et al. Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways[J]. Chemosphere, 2024, 358: 142124.
[45]Greger H K, Hanem L G E, Østgård H F, et al. Cognitive function in metformin exposed children, born to mothers with PCOS-follow-up of an RCT[J]. BMC Pediatr, 2020, 20(1): 60.
[46]Wouldes T A, Battin M, Coat S, et al. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes[J]. Arch Dis Child Fetal Neonatal Ed, 2016, 101(6): F488-F493. [47]Gordon H G, Atkinson J A, Tong S, et al. Metformin in pregnancy and childhood neurodevelopmental outcomes: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2024, 231(3): 308-314, e6.
[48]Dashtkoohi M, Noorafrooz M, Hantoushzadeh S. Concerns regarding the safety of metformin use in pregnancy[J]. Am J Obstet Gynecol, 2025, 232(3): e113.
[49]Anon. Diabetes in pregnancy: management from preconception to the postnatal period[M]. London: National Institute for Health and Care Excellence (NICE), 2020.
[50]Queensland Health. Gestational diabetes mellitus (GDM)[EB/OL]. [2025-09-01]. https://www.health.qld.gov.au/qcg.
[51]Anon. Management of diabetes in pregnancy: standards of care in diabetes-2025[J]. Diabetes Care, 2025,48(1 Suppl 1):S306-S320.
[52]Venkatesh K K, MacPherson C, Clifton R G, et al. Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study[J]. BMJ Open, 2024, 14(9): e091176.
|